The authors analyzed 92 inflammatory biomarkers and observed that interferon gamma and monocyte chemoattractant protein 3 (MCP-3) were associated with a greater risk (an odds ratio of 3.74 in the 8.5 years before the onset of the disease) to develop GCA, several years before the appearance of the first symptoms. This evidence concerns the gene IFNG and temporal arteritis.